#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Editorial

Czech version

Published in: Vnitř Lék 2022; 68(2): 79
Category: Editorial

Labels

Diabetology Endocrinology Internal medicine

ADA Standards of Medical Care in Diabetes 2022 – what’s new?

Oral semaglutide – Rybelsus®, the first GLP-1 receptor agonist for oral use in clinical practice

The position of SGLT2 inhibitors in current medical practice – update 2022

What do the new ESC Guidelines for the treatment of heart failure bring to internists?

Anticoagulation in cancer patients; new recommendations based on randomized clinical trials

Colorectal cancer in patients with diabetes – epidemiology, pathophysiology and applications for clinical practice

Any expectations from the more powerful dulaglutide?

Pituitary incidentaloma

Pharmacological possibilities of vitamin C in oncology

Article was published in

Internal Medicine

Issue 2

2022 Issue 2

Most read in this issue

#ADS_BOTTOM_SCRIPTS#